Literature DB >> 27923792

The fate of sulfate in chronic heart failure.

Anne M Koning1,2, Wouter C Meijers3, Isidor Minović4, Adrian Post4, Martin Feelisch5, Andreas Pasch6, Henri G D Leuvenink2, Rudolf A de Boer3, Stephan J L Bakker4, Harry van Goor7.   

Abstract

New leads to advance our understanding of heart failure (HF) pathophysiology are urgently needed. Previous studies have linked urinary sulfate excretion to a favorable cardiovascular risk profile. Sulfate is not only the end product of hydrogen sulfide metabolism but is also directly involved in various (patho)physiological processes, provoking scientific interest in its renal handling. This study investigates sulfate clearance in chronic HF (CHF) patients and healthy individuals and considers its relationship with disease outcome. Parameters related to renal sulfate handling were determined in and compared between 96 previously characterized CHF patients and sex-matched healthy individuals. Among patients, sulfate clearance was analyzed for associations with clinical and outcome parameters. In CHF patients, plasma sulfate concentrations are significantly higher, whereas 24-h urinary excretion, fractional excretion, and clearance of sulfate are significantly lower, compared with healthy individuals. Among patients, sulfate clearance is independently associated with diuretics use, creatinine clearance and 24-h urinary sodium excretion. Sulfate clearance is associated with favorable disease outcome [hazard ratio per SD increase 0.38 (95% confidence interval 0.23-0.63), P < 0.001]. Although significance was lost after adjustment for creatinine clearance, the decrease of sulfate clearance in patients is independent of this parameter, indicating that sulfate clearance is not merely a reflection of renal function. This exploratory study reveals aberrant sulfate clearance as a potential contributor to CHF pathophysiology, with reduced levels in patients and a positive association with favorable disease outcome. Further research is needed to unravel the nature of its involvement and to determine its potential as a biomarker and target for therapy.NEW &amp; NOTEWORTHY Sulfate clearance is decreased in chronic heart failure patients compared with healthy individuals. Among patients, sulfate clearance is positively associated with favorable disease outcome, i.e., a decreased rehospitalization rate and increased patient survival. Hence, decreased sulfate clearance may be involved in the pathophysiology of heart failure.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  chronic heart failure; disease outcome; hydrogen sulfide; renal handling; sulfate

Mesh:

Substances:

Year:  2016        PMID: 27923792      PMCID: PMC5402010          DOI: 10.1152/ajpheart.00645.2016

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  33 in total

1.  Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions.

Authors:  Nilkantha Sen; Bindu D Paul; Moataz M Gadalla; Asif K Mustafa; Tanusree Sen; Risheng Xu; Seyun Kim; Solomon H Snyder
Journal:  Mol Cell       Date:  2012-01-13       Impact factor: 17.970

2.  Relationship of dietary intake of sulphur amino-acids to urinary excretion of inorganic sulphate in man.

Authors:  Z I Sabry; S B Shadarevian; J W Cowan; J A Campbell
Journal:  Nature       Date:  1965-05-29       Impact factor: 49.962

3.  Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle.

Authors:  Zheng Sun; Nikhil Singh; Shannon E Mullican; Logan J Everett; Li Li; Lijun Yuan; Xi Liu; Jonathan A Epstein; Mitchell A Lazar
Journal:  J Biol Chem       Date:  2011-08-01       Impact factor: 5.157

4.  Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.

Authors:  Chao-Hung Wang; Mei-Ling Cheng; Min-Hui Liu; Ming-Shi Shiao; Kuang-Hung Hsu; Yu-Yen Huang; Cheng-Cheng Lin; Jui-Fen Lin
Journal:  Heart Vessels       Date:  2015-07-02       Impact factor: 2.037

Review 5.  Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.

Authors:  David J Polhemus; David J Lefer
Journal:  Circ Res       Date:  2014-02-14       Impact factor: 17.367

6.  High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.

Authors:  Joost C van den Born; Anne-Roos S Frenay; Stephan J L Bakker; Andreas Pasch; Jan-Luuk Hillebrands; Hiddo J Lambers Heerspink; Harry van Goor
Journal:  Nitric Oxide       Date:  2016-03-04       Impact factor: 4.427

Review 7.  State of the art: using natriuretic peptide levels in clinical practice.

Authors:  Alan Maisel; Christian Mueller; Kirkwood Adams; Stefan D Anker; Nadia Aspromonte; John G F Cleland; Alain Cohen-Solal; Ulf Dahlstrom; Anthony DeMaria; Salvatore Di Somma; Gerasimos S Filippatos; Gregg C Fonarow; Patrick Jourdain; Michel Komajda; Peter P Liu; Theresa McDonagh; Kenneth McDonald; Alexandre Mebazaa; Markku S Nieminen; W Frank Peacock; Marco Tubaro; Roberto Valle; Marc Vanderhyden; Clyde W Yancy; Faiez Zannad; Eugene Braunwald
Journal:  Eur J Heart Fail       Date:  2008-08-29       Impact factor: 15.534

Review 8.  Enzymology of H2S biogenesis, decay and signaling.

Authors:  Omer Kabil; Ruma Banerjee
Journal:  Antioxid Redox Signal       Date:  2013-06-07       Impact factor: 8.401

9.  Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial).

Authors:  Nicolas F Schroten; Willem P T Ruifrok; Lennaert Kleijn; Martin M Dokter; Herman H Silljé; Hiddo J Lambers Heerspink; Stephan J L Bakker; Ido P Kema; Wiek H van Gilst; Dirk J van Veldhuisen; Hans L Hillege; Rudolf A de Boer
Journal:  Am Heart J       Date:  2013-06-24       Impact factor: 4.749

Review 10.  Sulphate in pregnancy.

Authors:  Paul A Dawson; Aoife Elliott; Francis G Bowling
Journal:  Nutrients       Date:  2015-03-04       Impact factor: 5.717

View more
  5 in total

1.  Statistical considerations in reporting cardiovascular research.

Authors:  Merry L Lindsey; Gillian A Gray; Susan K Wood; Douglas Curran-Everett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

2.  The pleiotropic effects of hydrogen sulfide.

Authors:  Nancy L Kanagy; Christopher G Kevil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-03       Impact factor: 4.733

3.  Rapid free thiol rebound is a physiological response following cold-induced vasoconstriction in healthy humans, primary Raynaud and systemic sclerosis.

Authors:  Amaal Eman Abdulle; Anniek M van Roon; Andries J Smit; Andreas Pasch; Matijs van Meurs; Hendrika Bootsma; Stephan J L Bakker; Mohammad Y Said; Bernadette O Fernandez; Martin Feelisch; Harry van Goor; Douwe J Mulder
Journal:  Physiol Rep       Date:  2019-03

4.  Pushing arterial-venous plasma biomarkers to new heights: A model for personalised redox metabolomics?

Authors:  Andrew F Cumpstey; Magdalena Minnion; Bernadette O Fernandez; Monika Mikus-Lelinska; Kay Mitchell; Daniel S Martin; Michael P W Grocott; Martin Feelisch
Journal:  Redox Biol       Date:  2019-01-22       Impact factor: 11.799

Review 5.  Fighting Oxidative Stress with Sulfur: Hydrogen Sulfide in the Renal and Cardiovascular Systems.

Authors:  Joshua J Scammahorn; Isabel T N Nguyen; Eelke M Bos; Harry Van Goor; Jaap A Joles
Journal:  Antioxidants (Basel)       Date:  2021-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.